Mersana Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $338k | 146k | 2.32 |
| 2023-09-30 | $428k | 337k | 1.27 |
| 2023-06-30 | $4.6M | 1.4M | 3.29 |
| 2023-03-31 | $12M | 2.9M | 4.11 |
| 2022-12-31 | $12M | 2.0M | 5.86 |
| 2022-06-30 | $8.6M | 1.9M | 4.62 |
| 2022-03-31 | $6.6M | 1.7M | 3.99 |
| 2021-12-31 | $7.5M | 1.2M | 6.22 |
| 2021-09-30 | $11M | 1.1M | 9.43 |
| 2021-03-31 | $19M | 1.2M | 16.18 |
| 2020-12-31 | $28M | 1.0M | 26.61 |
| 2020-09-30 | $11M | 596k | 18.62 |
| 2020-06-30 | $11M | 452k | 23.40 |
| 2019-12-31 | $368k | 64k | 5.73 |
| 2019-09-30 | $116k | 73k | 1.58 |
| 2019-06-30 | $164k | 41k | 4.04 |
| 2019-03-31 | $128k | 24k | 5.28 |
| 2018-12-31 | $121k | 30k | 4.09 |
| 2018-09-30 | $336k | 34k | 10.00 |
| 2018-06-30 | $247k | 14k | 17.89 |
| 2018-03-31 | $381k | 24k | 15.75 |
| 2017-12-31 | $247k | 15k | 16.44 |
| 2017-06-30 | $699k | 50k | 13.98 |